New York81°

New York81°

Denver61°
July 30, 2020 CONTACT

Hemptown Archives - Hemp Market Report

Julie AitchesonJulie AitchesonNovember 15, 2019
Hemptown.jpg

2min00

Product: Hemptown Chew CBD Gum (Mint Flavor) by Hemptown USA

Company: Hemptown USA

Hemptown Chew CBD Gum has the look of a TUMS tablet, but softens easily in the mouth with a subtle yet strong enough mint flavor to overpower any of the musty grassiness of many CBD-infused products. As with other “natural” chewing gums using sweeteners such as sorbitol, mannitol, xylitol, and/or stevia (Hemptown Chews uses all of these), the flavor quickly dissipates while the texture becomes rubbery, making chewing laborious. However, with a stated fifteen milligrams of CBD and five milligrams of CBG (Cannabigerol, the “chemical parent” of CBD and THC) per serving, Hemptown Chews have a lot more to offer the consumer than a more supple stick of Wrigley’s.

The packaging is pleasingly minimalist, with two servings per pouch. The fact that the gum is sugar-free, gluten-free, and has zero calories appealed to my inner health nut, while the high concentration of CBD and of CBG prompted me to keep working the gum over after it had lost its flavor and initial marshmallowy texture. Within about five minutes, the familiar lassitude I associate with CBD descended with a pleasant drop of my shoulders and a loosening in my chest that signaled a switch from the fight-or-flight mode of my workday to the rest-and-digest vibe I slip into once I clock out for the evening. Unfortunately, it was only twelve-thirty.

Though the physical relaxation was pleasant, for me the effect on my cognitive function was too strong. I enjoyed the gum’s swift action and its potency (if not the mouthfeel and flavor after the first minute or so) but would restrict my use of this product to times when efficiency and laser focus are not required. While perhaps well-suited for those CBD users with a higher tolerance, for me, Hemptown Chew is a “functional gum” whose function will be purely recreational.


StaffStaffNovember 4, 2019
CBG.jpg

8min00

While CBD is exploding across all markets, Cannabigerol or CBG could be just as important. It is often described as the “Mother of all cannabinoids” because it is the chemical source of all other plant-based cannabinoids. Like CBD, CBG delivers no overt psychoactivity, making it safe for children, seniors, and those in sensitive job positions.

In 2018 The National Center for Complementary and Integrative Health (NCCIH) announced an intent to research minor cannabinoids including CBG that could help manage painThe NCCIH wrote that minor cannabinoids are defined as all and any cannabinoids from the cannabis herb other than Δ9-tetrahydrocannabinol (Δ9-THC). Cannabinoids and terpenes of particular interest include: Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol (CBN), Cannabichromene (CBC), Myrcene, ß-caryophyllene, Limonene, a-terpineol, Linalool, a-phellandrene, a-pinene, ß-pinene, Y-terpinene, and a-humulene.

“This initiative intends to support highly innovative basic and/or mechanistic studies in appropriate model organisms and/or human subjects aiming to identify, describe and predict if minor cannabinoids and/or terpenes can help treat pain. The mechanisms and processes underlying potential contribution of minor cannabinoids and terpenes to pain relief and functional restoration in patients with different pain conditions may be very broad.”

Consumers don’t hear very much about CBG because it is difficult to produce and expensive to boot. The cannabis plants make lots of THC and CBD, but CBG is usually only present in small percentages. That is why it is called a “minor”cannabinoid. CBG can be five to six times more expensive than CBD.

In September, Hemptown USA released a new research-based CBG whitepaper that includes research from over 60 clinical studies with historical data and analysis.

The report noted that Cannabigerol or CBG, is one of a family of more than 100 molecules called cannabinoids that are produced by cannabis. “CBG is unique among its peers due to the pivotal role that it plays in the synthesis of other cannabinoids and the overall chemical composition of the plant.” According to a 2018 research study, CBG binds with both CB1 and CB2 receptors. This gives CBG greater potential efficacy than cannabinoids that bind with only a single type of receptor, such as CB2. Reported the study’s authors, “The results indicate that CBG is indeed effective as a regulator of endocannabinoid signaling.”

The paper wrote, “You’ve probably heard of popular chemotypes like Sativa and Indica, or the lesser-known Ruderalis, but did you know scientists have discovered a possible 4th chemotype? Research goes back as far as 1987, but more recently, studies in 2002 and 2005 have documented a fourth chemotype that features extremely large volumes of CBG and very low levels of THC.” 

The research found that CBG-dominant chemotypes consistently offer significantly larger volumes of the “companion molecule” CBD. Those molecules join forces to provide additional effectiveness for systemic inflammation, anxiety, and pain. Some studies suggest that CBGV also boosts CBD metabolism within the body, making CBD more potent when paired with this cannabinoid. 

Numerous Studies Cited In White Paper

The white paper lists an exhaustive compilation of CBG studies including a 2018 study entitled “Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors” that was published in the journal Frontiers in Pharmacology investigated the binding affinity of CBG with the CB1 and CB2 receptors of the ECS. The study reported, “The results indicate that CBG is indeed effective as [a] regulator of endocannabinoid signaling.” 

A 2017 research study involving mice entitled “Beneficial Effect of the Non-psychotropic Plant Cannabinoid Cannabigerol on Experimental Inflammatory Bowel Disease” that was published in the journal Biochemical Pharmacology explored how CBG might help those suffering from inflammatory bowel disease (IBD). “We investigated the effect of CBG, a non-psychotropic cannabis-derived cannabinoid, in a murine model of colitis,” reported the study. 

Stated the researchers, “CBG attenuated murine colitis, reduced nitric oxide production in macrophages (effect being modulated by the CB2 receptor),” concluding that “CBG could be considered for clinical experimentation in IBD patients.” 

A 2016 research study entitled “Cannabigerol is a Novel, Well-tolerated Appetite Stimulant” that was published in the journal Psychopharmacology investigated the ability of CBG to stimulate appetite (hyperphagia) and was the first to prove that this molecule increases appetite. The study also identified the safety profile of CBG, reporting that it conveyed “no adverse effects on any parameter in the neuromotor tolerability test battery.

 


Debra BorchardtDebra BorchardtMay 14, 2019
Hemp-Growing-small_1.jpg

4min00

Hemptown Organics Corp. raised  C$24 million in a round of financing from Canaccord Genuity Corp.who served as the lead agent on the brokered portion of the financing on behalf of a syndicate of investors that included Sprott Capital, Beacon Securities, and Pacific International.

The investment will allow Hemptown to embark on a multi-state expansion, purchase $5.5M in Oregon CBD seeds, begin the build-out of its processing and extraction facilities, research team, as well as planting and harvesting of its 2019 crop of feminized hemp seeds.

“Successful companies in this sector will be those with the ability to build a scalable, vertically integrated multi-state company,” stated Rod Wolterman, Founder and Chairman, Hemptown USA. “We have assembled a well-respected team that has already produced some of the highest quality feminized hemp in the country here in Southern Oregon’s Emerald Triangle. The capital infusion will allow us to expand operations to Colorado, Kentucky, Northern California, ramp up processing capabilities and develop disruptive product formulations in the CPG sector. Needless to say, we’re very excited to be executing on our vision and delivering sustainably grown feminized hemp flower and biomass on a commercial scale.”

With this capital infusion, Hemptown USA is now poised to become a formidable multi-state operation within this rapidly growing industry. Hemptown reported that it had a first-year yield of 110,000 lbs of feminized hemp biomass. The company said it is one of the largest CBG producers in the U.S. with our purchase of 1 million rare CBG seeds for the 2019 growing season. It also said that it is producing some of the world’s most coveted strain profiles containing 15% – 20% full spectrum CBD, CBG and other cannabinoids and terpenes.

Currently, the company is growing 1500 acres in Oregon, Kentucky, and Colorado with the capability to more than double the acreage in 2020 and each year after.

Looking Ahead

Hemptown plans to continue farming more novel cannabinoid strains in large quantities. Such as CBC, CBDV, and CBGV. The company also plans on acquiring a cGMP nutraceutical facility to develop unique cannabinoid products for the health and wellness industry.

“Successful companies in this sector will be those with the ability to build a scalable, vertically integrated multi-state company,” stated Rod Wolterman, Founder and Chairman, Hemptown USA. “We have assembled a well-respected team that has already produced some of the highest quality feminized hemp in the country here in Southern Oregon’s Emerald Triangle. The capital infusion will allow us to expand operations to Colorado, Kentucky, Northern California, ramp up processing capabilities and develop disruptive product formulations in the CPG sector. Needless to say, we’re very excited to be executing on our vision and delivering sustainably grown  feminized hemp flower and biomass on a commercial scale.”



About Us

The Hemp Market Report will target news from the fast growing worlds of cannabidiol (CBD) and hemp. As a sister site to the Green Market Report, HMR will cover financial stories, but also take a look at lifestyle news as well. The Hemp Market Report will also publish sponsored content as we seek to expand our content offerings.


READ MORE



Recent Tweets

@GreenMarketRpt – 23 hours

$SMG Scotts Miracle-Gro Increases Guidance As Hawthorne Sales Hit $300 Million

@GreenMarketRpt – 4 days

RT : Psychedelic-assisted therapy involves psychotherapeutic practices with a psychedelic as an adjunct. Research shows this has…

Back to Top

You have Successfully Subscribed!